SARS-CoV-2-specific CD8 T cells were detected at baseline in both previously COVID-19 infected and non-infected volunteers, cells that were primed by natural infection and exposure to SARS-CoV-2 or to other coronaviruses within the beta sarbecoCoV group (or may suggest previous sterile immunity) [18]. The gene discussed is CD8A; the disease is COVID-19.